FDA NDC Directory · JSON-LD · Markdown

Rifadin IV

NDC 0068-0597 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namerifampin
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryNew Drug Application (innovator) · App NDA050627
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsRIFAMPIN (600 mg/10mL)
Marketing started19890525
Marketing ended20260930
Package count1

External sources

Source: openFDA. Public-domain (CC0).